ECO Animal Health Group (EAH LN) Margin beat drives EBITDA upgrade | Summit Therapeutics (SUMM LN) Microbiome preservation data on ridinilazole published in PLOS ONE | Verona Pharma (VRP LN) Conviction Opportunity in Pulmonary Disease
03 Aug 2018
Morning Song
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
ECO Animal Health Group plc (EAH:LON), 85.5 | Summit Therapeutics Inc (SMMT:NAS), 0 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0
- Published:
03 Aug 2018 -
Author:
N+1 Singer Team -
Pages:
9
ECO Animal Health Group (EAH LN) Margin beat drives EBITDA upgrade | Summit Therapeutics (SUMM LN) Microbiome preservation data on ridinilazole published in PLOS ONE | Verona Pharma (VRP LN) Conviction Opportunity in Pulmonary Disease